Please send all feedback to: doc@psychiatrix.com
Los Angeles area residents call 818-991-8376 for appt.
The FDA has approved (August 2003) a new medication for the treatment of Bipolar Disorder. This medication belongs to the class known as antiepileptic drugs (AED).
Lamictal is the first drug approved for control of the maintenance phase of Bipolar Disorder since Lithium. Lamictal is particularly effective in preventing depressive episodes.
However, it is effective in preventing manic relapses as well. Thus, this medication fills a gap in the effective treatment of Bipolar Disorder.
Some of the key advantages of Lamictal include:
1 - Particularly effective in preventing DEPRESSIVE episodes.
2 - Does not require monitoring of serum levels (unlike Lithium and Depakote).
3 - Can be used in combination with other medication (including Lithium and Depakote).
4 - Does not cause weight gain (a problem with Lithium and Depakote).
As with all medications there are potential side effects and other medical considerations to be evaluated prior to and during medication treatment. It is essential to consult with a psychiatrist, or other physician, knowledgeable about Bipolar Disorder and related medical and psychiatric conditions.
Lamictal is marketed in the US by GalaxoSmithKline.
__________________
Please send all feedback to: doc@psychiatrix.com
Los Angeles area residents call 818-991-8376 for appt.